Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price rose 3.5% during mid-day trading on Friday . The stock traded as high as $0.67 and last traded at $0.67. 8,804,674 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 31,240,242 shares. The stock had previously closed at $0.65.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group upped their target price on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Tilray currently has a consensus rating of "Hold" and a consensus target price of $2.70.
Check Out Our Latest Analysis on Tilray
Tilray Price Performance
The firm has a market cap of $631.04 million, a PE ratio of -2.24 and a beta of 2.13. The firm's fifty day simple moving average is $0.91 and its two-hundred day simple moving average is $1.30. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million for the quarter, compared to analysts' expectations of $216.34 million. The business's revenue for the quarter was up 8.7% on a year-over-year basis. As a group, research analysts expect that Tilray Inc will post -0.2 EPS for the current year.
Institutional Trading of Tilray
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Lido Advisors LLC purchased a new stake in Tilray during the 4th quarter valued at approximately $28,000. Verdence Capital Advisors LLC purchased a new position in Tilray during the fourth quarter valued at $29,000. Dudley Capital Management LLC bought a new stake in Tilray in the 4th quarter valued at $29,000. Ameritas Advisory Services LLC purchased a new stake in Tilray in the 4th quarter worth $32,000. Finally, Newman Dignan & Sheerar Inc. boosted its holdings in shares of Tilray by 61.9% during the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares during the last quarter. Institutional investors own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
